| Emily Bennett, | |
|
3703 W Lake Ave, Suite 200, Glenview, IL 60026-1223 | |
| (847) 998-1188 | |
| Not Available |
| Full Name | Emily Bennett |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3703 W Lake Ave, Glenview, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043662620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Emily Bennett, 3703 W Lake Ave, Suite 200, Glenview, IL 60026-1223 Ph: (847) 998-1188 | Emily Bennett, 3703 W Lake Ave, Suite 200, Glenview, IL 60026-1223 Ph: (847) 998-1188 |
News Archive
At the 17th annual Society for Biomolecular Sciences 2011 conference in Orlando, PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced the expansion of its epigenetic detection reagents portfolio specifically validated for drug discovery and life sciences research.
People diagnosed with diabetes spend over $4,100 more each year on medical costs than people who don't have diabetes, a gap that increases substantially each year following the initial diagnosis, according to a study published online today in the journal Diabetes Care.
Prostate cancer is the most common cancer among males in the United States. Approximately, 180,000 men are diagnosed each year, and approximately 95 percent of these men have localized disease that is potentially curable.
A team led by Massachusetts General Hospital (MGH) scientists has developed a new microfluidic tool for quickly and accurately isolating neutrophils - the most abundant type of white blood cell - from small blood samples, an accomplishment that could provide information essential to better understanding the immune system's response to traumatic injury. The system, described in a Nature Medicine paper that received advance online release, also can be adapted to isolate almost any type of cell.
A new study published on the medRxiv* preprint server analyzed the trajectories of anti-SARS-CoV-2 antibodies in patients from the RituxiVac study were compared to healthy volunteers. In addition, they investigated the immunogenicity of a third vaccine dose in previously non-responding patients.
› Verified 3 days ago
Ms. Kelly Watson Laughlin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2591 Compass Rd, Suite 100, Glenview, IL 60026 Phone: 847-729-6220 Fax: 847-729-1116 | |
Miss Meghan Mcmahon, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3703 W Lake Ave, Suite 200, Glenview, IL 60026 Phone: 847-998-1188 | |
Mrs. Karla Rae Faems, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3703 W Lake Ave, Suite 200, Glenview, IL 60026 Phone: 847-998-1188 | |
Allison M Raino, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1308 Waukegan Road, Suite 103, Glenview, IL 60025 Phone: 877-486-4140 | |
Miss Suzanne Michele Stroemer, MACCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3703 W Lake Ave, Suite 200, Glenview, IL 60026 Phone: 847-998-1188 | |
Janice Kim, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1920 Waukegan Rd Ste 212, Glenview, IL 60025 Phone: 404-917-4969 | |
Ashley Redwine, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2600 Compass Rd, Glenview, IL 60026 Phone: 877-787-3430 |